Figure 1.
Dose-escalation of 111In-girentuximab-F(ab′)2. Uptake of 111In-girentuximab-F(ab′)2 in subcutaneous SCCNij153 tumors 24 h after injection. *p < 0.05.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.